April 20, 2024
Stocks & Bonds
[STOCK WATCH] JW Pharmaceutical falls 3.27%
[THE INVESTOR] As of June 20 10:25 A.M., JW Pharmaceutical declined 3.27%, compared with yesterday, to 48,850 won. It had increased 4.27% through the past month. Standard deviation, which indicates risk, records 2.1% over the same period over one month.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of JW Pharmaceutical was proper, while its volatility within 1 month was considerably higher than that of its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 2.0. The volatility of JW Pharmaceutical was the highest among its peer group, but the return-on-risk is not so low. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 7.2, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of JW Pharmaceutical was proper, while its volatility within 1 month was considerably higher than that of its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 2.0. The volatility of JW Pharmaceutical was the highest among its peer group, but the return-on-risk is not so low. However, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 7.2, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
